In 1998, the United Kingdom Prospective Diabetes Study (UKPDS) not only found a greater improvement in glycemic control in patients taking metformin compared with the conventional treatment arm, but also showed that metformin therapy resulted in a reduction in hypoglycemic events and weight gain compared with sulfonylureas and insulin. Here, INS is linked to diabetes mellitus.